| Andres Perez, MD | |
|
289 Ireland Ave, Ireland Army Community Hospital Emergency Deparment, Fort Knox, KY 40121-5111 | |
| (313) 550-2056 | |
| Not Available |
| Full Name | Andres Perez |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 289 Ireland Ave, Fort Knox, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164889176 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 41947 (Arizona) | Secondary |
| 207P00000X | Emergency Medicine | 4301406662 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andres Perez, MD Po Box 682785, Franklin, TN 37068-2785 Ph: (313) 550-2056 | Andres Perez, MD 289 Ireland Ave, Ireland Army Community Hospital Emergency Deparment, Fort Knox, KY 40121-5111 Ph: (313) 550-2056 |
News Archive
Indianapolis interventional medical device maker NICO Corporation and Toronto-based 3D visualization leader Synaptive Medical announced today at the Congress of Neurological Surgeons Annual Meeting that they have joined forces to integrate their innovative technologies for brain surgery.
A team of researchers from the US and Belgium applied a structure-based approach with early monitoring of cathepsin L inhibition along with SARS-CoV-2 3CLpro inhibition. They identified a potent and selective SARS-CoV-2 3CLpro inhibitor, ALG-097111, which has proven activity against SARS-CoV-2 in SARS-CoV-2 hamster models in vivo. This study is published in the journal, Biochemical and Biophysical Research Communications.
Adding higher frequencies to the American Academy of Pediatrics hearing test protocol helps detect adolescent hearing loss, according to a team of pediatricians and audiologists.
According to a recent analysis by SDI, a leading healthcare market insight and analytics firm, about half of patients beginning therapy on popular osteoporosis drugs discontinue their treatment within 6 months. Amgen's Prolia, which was recently approved for postmenopausal women with osteoporosis at high risk of fracture, or patients who could not tolerate other osteoporosis therapies, is the newest product to enter the market. Prolia differs from existing therapies as it is given every 6 months via injection.
› Verified 5 days ago
Dr. Ann Judith Burgardt, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 289 Ireland Ave, Ireland Army Community Hospital, Fort Knox, KY 40121 Phone: 502-624-9658 |